Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-29
2006-08-29
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S184000
Reexamination Certificate
active
07098207
ABSTRACT:
Novel imidazotriazinones of general formulaa method for the production and the pharmaceutical use thereof are disclosed.
REFERENCES:
patent: 6362178 (2002-03-01), Niewohner et al.
patent: 0526004 (1993-02-01), None
patent: 9428902 (1994-12-01), None
patent: 9924433 (1999-05-01), None
Matsumoto et al., J. Smooth Muscle Res. 39(4): 67-86, 2003.
Dumaitre, B., and Dodiac, N., “Synthesis and Cyclic GMP Phosphodiesterase Inhibitory Activity of a Series of 6-Phenylpyrazolo[3,4-d]pyrimidinones”, J. Med. Chem. 39: 1635-1644 (1996).
Lucas, K. A., et al., “Guanylyl Cyclases and Signaling by Cyclic GMP”, Pharmacological Reviews, 52(3): 375-413 (2000).
Bischoff Erwin
Dembowsky Klaus
Es-Sayed Mazen
Haning Helmut
Lampe Thomas
Balasubramanian Venkataraman
Bayer Pharmaceuticals Corporation
Pellegrino Susan M.
LandOfFree
Imidazotriazinones and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazotriazinones and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazotriazinones and the use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3649785